Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Tech Reporter.
Press releases published on April 28, 2025

Hudbay Signs Exploration Agreement with the Mosakahiken Cree Nation for the Talbot Deposit in Manitoba
TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) today announced the signing of an agreement with the Mosakahiken Cree Nation (“MCN”) on exploration activities in their traditional and ancestral …

Evoke Pharma to Present New Data Comparing Tardive Dyskinesia Incidence in Continuous vs Intermittent Metoclopramide Use at DDW 2025
SOLANA BEACH, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders with an emphasis on GIMOTI®, today announced that a new abstract …

Intent IQ Announces Availability of Bid Enhancement Solution on Google Cloud Marketplace
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Intent IQ, a privacy-forward, next-generation identity resolution leader, today announced Intent IQ’s innovative Bid Enhancement solution is now available on Google Cloud Marketplace. As a result, Google Cloud …

New MetaMask Metal Payment Card: Self-Custody Crypto Card With Direct Payments Unveiled by CompoSecure, Baanx and MetaMask
SOMERSET, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (“CompoSecure”) (NASDAQ: CMPO), a leader in metal payment cards, security, and authentication solutions, in collaboration with Baanx and MetaMask, today announced the launch of the …

reAlpha Tech Corp. Appoints Cristol Rippe as CMO
DUBLIN, Ohio, April 28, 2025 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (Nasdaq: AIRE) (“reAlpha” or the “Company”), a real estate technology company developing and commercializing artificial intelligence (“AI”) technologies, is pleased to announce the …

Jiayin Group Inc. Filed Annual Report on Form 20-F for Fiscal Year 2024
SHANGHAI, China, April 28, 2025 (GLOBE NEWSWIRE) -- Jiayin Group Inc. (“Jiayin” or the “Company”) (NASDAQ: JFIN), a leading fintech platform in China, today announced that it has filed its annual report on Form 20-F (the "Annual Report") for the fiscal …

Point of Care Diagnostics Market Size to Reach $82.95 Bn by 2028 Globally, at 12.7% CAGR: The Insight Partners
US …

Six Cybersecurity Products Achieve AV-Comparatives’ 2025 Anti-Tampering Certification
AV-Comparatives has announced the results of its 2025 Defense Evasion (Anti-Tampering) Certification Test. INNSBRUCK, TYROL, AUSTRIA, April 28, 2025 /EINPresswire.com/ -- After rigorous testing against a wide array of sophisticated attack scenarios …

NobleAI to Present at 2025 AOCS Annual Meeting
PORTLAND, Ore., April 28, 2025 (GLOBE NEWSWIRE) -- NobleAI, the leader in practical AI solutions for innovation in the chemicals and energy industries, today announced that it will present with ExxonMobil at the upcoming American Oil Chemists' Society ( …

iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring
Findings in a younger, commercially insured population build on Medicare-based CAMELOT results, expanding the generalizability of Zio LTCM's clinical impact across patient groups. Latest data showed Zio LTCM was associated with higher diagnostic yield and …

Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval
BERKELEY, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, today reviewed its major accomplishments of the …

80% of the EVX-01 vaccine targets trigger a tumor-reactive immune response - Evaxion presents striking EVX-01 data at the AACR Annual meeting
80% of EVX-01 vaccine targets triggered a tumor-specific immune response, a substantially higher frequency than what has been reported for other similar vaccine candidates The data underscores the precision of Evaxion’s AI-Immunology™ platform in selecting …

ImPact Biotech Presents Updated Efficacy Data from Evaluation of Padeliporfin VTP in LG UTUC and Intermediate-Risk Prostate Cancer at AUA 2025
– Complete response (CR) observed in 79% (26/33) of evaluable patients with low-grade upper tract urothelial cancer (UTUC) who completed the Induction Treatment Phase (ITP) of the ENLIGHTED Phase 3 trial evaluating Padeliporfin VTP in UTUC – – Padeliporfin …

BigCommerce and Silk Commerce Launch Distributed Ecommerce Hub to Power Scalable Storefront Networks for Dealers, Distributors and Franchises
AUSTIN, Texas, April 28, 2025 (GLOBE NEWSWIRE) -- BigCommerce (Nasdaq: BIGC), an open SaaS, composable ecommerce platform for fast-growing and established B2C and B2B brands and retailers, today announced the launch of Distributed Ecommerce Hub, a new …

Calidi Biotherapeutics Announces IL15 Superagonist as First Payload to be Delivered by Systemic Antitumor Virotherapy Platform at AACR Annual Meeting
SAN DIEGO, April 28, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced the selection of IL15 …

Northstrive Biosciences Co-Founder Featured on Bear Bull Traders Following Announcement of Positive FDA Response Supporting Submission of IND for EL-22 Phase 2 Clinical Trial
NEWPORT BEACH, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Northstrive Biosciences Inc. (“Northstrive”), a subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB) (the “Company,” “PMGC,” “we,” or “our”), is proud to announce that Co-Founder Deniel Mero was recently …

Adagene Appoints John Maraganore, Ph.D. as Executive Advisor
- Biotech luminary to mentor C-suite and provide strategic guidance - SAN DIEGO and SUZHOU, China, April 28, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of antibody-based therapies, …

Chemomab Reports New Positive Clinical Data at EASL 2025 Supporting Nebokitug’s Impact in Primary Sclerosing Cholangitis and Related Diseases
New Analyses of PSC Data from Phase 2 SPRING Trial Show that Treatment with Nebokitug Is Associated with Dose-Dependent and Significant Improvements in Multiple Inflammatory and Fibrotic Biomarkers Further Confirms the Clinical Potential of Nebokitug As a …

Kura Oncology Announces First Patients Dosed in Phase 1 Combination Trial of Ziftomenib for the Treatment of Advanced GIST
– Phase 1 dose-escalation study to evaluate ziftomenib in combination with imatinib in patients with advanced GIST after imatinib failure – – Combination of ziftomenib and imatinib shows robust and durable antitumor activity in imatinib-sensitive and …

BitMart Shines at TOKEN2049 Dubai: A Pinnacle Moment of Innovation and Global Impact
Dubai, UAE, April 28, 2025 (GLOBE NEWSWIRE) -- From April 30 to May 1, 2025, the annual premier event in the crypto and blockchain space, TOKEN2049, will make its grand debut at Madinat Jumeirah in Dubai. As a Platinum Sponsor, BitMart will showcase its …